 | | | | Swiss biotech group Idorsia on Friday lifted the lid off a 2019 deal for its investigational epilepsy medicine, revealing the pact that is potentially worth more than $400 million is with U.S.-based Neurocrine Biosciences. | | |
| | | The U.S. Food and Drug Administration approved Blueprint Medicines Corp's oral therapy to treat a rare form of cancer that affects the stomach and small intestine, the agency said on Thursday. | | |
| | | U.S. private equity firm Blackstone Group Inc has secured $3.4 billion from investors for its first fund dedicated to investments in the life sciences sector, targeting $4.6 billion in total, a regulatory filing showed on Thursday. | | |
| | | (Reuters Health) - Kids who are exposed to air pollution in the womb may have higher blood sugar levels during childhood than kids without this exposure, according to a study that suggests particle pollution could be an environmental risk factor for diabetes. | | |
| | | (Reuters Health) - Lack of insurance may be a major cause of delayed breast cancer detection in racial and ethnic minority women in the U.S., a new study suggests. | | |
| | | (Reuters Health) - Young children with mild apnea who have their tonsils removed may sleep a little better than kids who don't get tonsillectomies, but a new study suggests surgery won't improve cognitive function. | | |
| | | U.S. health officials on Thursday reported 2 more deaths from a mysterious respiratory illness tied to vaping, taking the total death toll to 57. | | |
| | | Bristol-Myers Squibb Co is confident it will receive U.S. approvals for all three experimental drugs tied to a potentially higher payout for Celgene shareholders under terms of its acquisition of the U.S. biotech company, Bristol's chief medical officer said. | | |
| | | (Reuters Health) - An effort to map genomes across Asia has the potential to find novel gene variants affecting disease and responses to drugs, and to reveal the complex origins of Asian populations, early results suggest. | | |
| | | (Reuters Health) - Less than one third of teens and young adults who overdose on opioids receive addiction treatment afterward, and the few who do get help receive counseling instead of medication to combat substance misuse, a U.S. study suggests. | | |
| | | Amag Pharmaceuticals Inc said on Thursday chief executive officer would step down and it plans to divest two of its women's health drugs, bowing to pressure from investor Caligan Partners that has long urged it to hive off the slow-growing unit. | | |
|
| |
